Vanda Pharmaceuticals (VNDA) Amortization - Intangibles (2010 - 2026)

Vanda Pharmaceuticals has disclosed Amortization - Intangibles across 17 years of filings, most recently posting $2.0 million for Q1 2026.

• Amortization - Intangibles for Q1 2026 came in at $2.0 million, up 13.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.3 million (up 2.67% YoY), and the FY2025 annual result was $7.0 million, down 3.66% from the prior year.
• Amortization - Intangibles came in at $2.0 million for Q1 2026 at Vanda Pharmaceuticals, up from $1.7 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $2.0 million in Q1 2024 to a low of $379000.0 in Q3 2022.
• The 5-year median for Amortization - Intangibles is $1.7 million (2025), against an average of $1.2 million.
• Across the five-year window, Amortization - Intangibles surged 432.45% in 2024 and declined 13.18% in 2025, its largest moves.
• Vanda Pharmaceuticals' Amortization - Intangibles stood at $416000.0 in 2022, then soared by 129.09% to $953000.0 in 2023, then soared by 83.84% to $1.8 million in 2024, then slipped by 2.57% to $1.7 million in 2025, then climbed by 16.4% to $2.0 million in 2026.
• The last three Amortization - Intangibles figures came in at $2.0 million (Q1 2026), $1.7 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.